We have announced the appointment of three senior leaders to take on the role of managing directors alongside Thomas Otto and Peter Soelkner. As of January 1, 2025, Henryk Badack, Titus Ottinger and Carsten Press will join the management team to continue guiding Vetter on its path of sustainable growth.
“We at Vetter are committed to investing in our future and the continuous successes of our customers,” shared Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family.
“By expanding the managing directors’ team, we are continuing the course for a sustainably successful future and further growth. Ultimately, we view this enhancement as a commitment to meeting the increasingly complex needs and expectations of our global customer base, in order to take care for patients in need worldwide. We take great pride in welcoming our three new managing directors to their upcoming roles.”
Henryk Badack will lead the company’s quality and development service departments. In his prior role, he served as Senior Vice President Technical Services and Internal Project Management where he was responsible for all internal, technical and infrastructure projects as well as the plant and site development, environmental health and safety, and Vetter Optimization Systems. He also previously led the company’s global sustainability initiatives, starting with the company in 2003.
Titus Ottinger will continue to lead finance and controlling, moving from Senior Vice President Finance & Controlling to Managing Director. He has been responsible for the company’s finances and external accounting. Risk management, insurance, and information for controlling business processes are likewise under his guidance. He originally joined Vetter in 2004.
Carsten Press joins the Managing Directors’ team with responsibility for the company’s supply chain management and human resources departments. Previously, he served as Senior Vice President Global Sales Organization & Supply Chain Management where he oversaw the global sales and supply chain organization along with product management and marketing. He has been with the company since 2009.
Thomas Otto and Peter Soelkner will both continue their successful leadership roles within the company. Under their guidance, the pharmaceutical service provider has experienced a remarkable positive development in the past decades. Thomas Otto will continue to lead the production/engineering and technical service/internal project management departments. He has served as a Managing Director since 2002. Peter Soelkner, serving as a Managing Director since 2008, will continue his role with a focus on corporate development and global sales.
The expansion of the management board takes into account the departments’ increasing growth and importance. It signals our role as a growing, global and independent operating industry leader.
